Development, Validation and Clinical Utility of a Risk Prediction Model for Maternal and Neonatal Adverse Outcomes in Pregnant Women with Hypothyroidism
Cuixiang Shao,Qi Chen,Siwen Tang,Chaowen Wang,Renjuan Sun
DOI: https://doi.org/10.2147/jmdh.s457818
2024-05-01
Journal of Multidisciplinary Healthcare
Abstract:Cuixiang Shao, 1, 2 Qi Chen, 3 Siwen Tang, 4 Chaowen Wang, 1 Renjuan Sun 5 1 Department of Obstetrics, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214000, People's Republic of China; 2 Wuxi Medical College, Jiangnan University, Wuxi, Jiangsu, 214122, People's Republic of China; 3 Department of Gastroenterology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214000, People's Republic of China; 4 Department of Intensive Care Unit, First People 's Hospital of Pinghu, Pinghu, Zhejiang, 314299, People's Republic of China; 5 Department of Nutrition, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214000, People's Republic of China Correspondence: Renjuan Sun, Department of Nutrition, Affiliated Hospital of Jiangnan University, 1000 Hefeng Road, Wuxi, Jiangsu, 214000, People's Republic of China, Tel +86 13813479833, Email Purpose: This study aimed to create, verify and assess the clinical utility of a prediction model for maternal and neonatal adverse outcomes in pregnant women with hypothyroidism. Methods: A prediction model was developed, and its accuracy was tested using data from a retrospective cohort. The study focused exclusively on female patients diagnosed with hypothyroidism who were admitted to a tertiary hospital. The development and validation cohort comprised individuals who gave birth between 1 October 2020 and 31 December 2022. The primary outcome was a combination of crucial maternal and newborn problems (eg premature births, abortions and neonatal asphyxia). The prediction model was developed using logistic regression. Evaluation of the model's performance was conducted based on its ability to discriminate, calibrate and provide clinical value. Results: In total, nine variables were chosen to develop the predictive model for adverse maternal and neonatal outcomes during pregnancy with hypothyroidism. The area under the curve of the model for predicting maternal adverse outcomes was 0.845, and that for predicting neonatal adverse outcomes was 0.685. The calibration plots showed good agreement between the nomogram predictions and the actual observations in both the training and validation cohorts. Furthermore, decision curve analysis suggested that the nomograms were clinically useful and had good discriminative power to identify high-risk mother–infant cases. Conclusion: Two models to predict the risk probability of maternal and neonatal adverse outcomes in pregnant women with hypothyroidism were developed and verified to assist physicians in evaluating maternal and neonatal adverse outcomes throughout pregnancy with hypothyroidism and to facilitate decision-making regarding therapy. Keywords: pregnancy with hypothyroidism, maternal and neonatal adverse outcomes, nomogram, forecasting model The most prevalent thyroid dysfunction observed during pregnancy is hypothyroidism, which can manifest in both overt and subclinical forms. The prevalence of thyroid dysfunction in women of reproductive age who are not pregnant has been found to be 17.2%. 1 Based on a meta-analysis of 97 studies, the estimated prevalence of hypothyroidism during pregnancy is 0.4%–13.1%, and that of subclinical hypothyroidism is 3.3%–42.9%. 2 Research has indicated that even mild hypothyroidism can result in adverse short-term outcomes for the mother and infant as well as long-term intellectual disability in the infant. 3 Hypothyroidism in pregnancy increases the risk of conditions such as preterm delivery, spontaneous abortion and gestational diabetes, and it can even result in death for both mother and child. Accurate identification of those at risk for maternal and neonatal adverse outcomes and early intervention among pregnant women with hypothyroidism could help improve maternal and neonatal prognosis. Unfortunately, research has shown that the diagnostic reference ranges are not necessarily the best cut-off for identifying pregnancies at high risk of adverse outcomes. 4 Moreover, the risk of maternal and neonatal adverse outcomes also depends on various factors, such as lipid differences 5 and pregnancy complications. 6 An increasing number of research works 7–9 are finding many risk factors associated with adverse maternal and neonatal outcomes, such as lipid levels, bisphenol A, retinol-binding protein 4, and first trimester thyroid stimulating hormone. However, these studies have mostly focused on individual components, and there is currently no comprehensive model available to predict the overall risk of maternal and neonatal adverse outcomes. Therefore, the aim of this study is to explore the risk factors leading to a -Abstract Truncated-
health care sciences & services